Catalyst Wire Dossier Catalyst Wire Dossier

BGB-23339

· BeiGene
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGB-23339, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human, Single- and Multiple-Ascending Dose and Food-Effect Study of BGB-23339 in Healthy Participants [Phase 1]

See pricing